PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

4 Things I Learned from Not Being Able to Attend Trade Shows

September 19, 2020

It’s no secret that trade shows are a staple in the medical device and packaging industry. They are a place where everyone comes together to learn about the newest technologies, innovations and best practices, and network with friends and colleagues....

Learn More

Confessions of a Packaging Leader: David Hardin

September 19, 2020

I started my career with Richards Medical in Memphis, Tennessee, working in a product design role that later evolved into packaging engineering. At the time, I had no experience in packaging, and was therefore learning on the job. My degree was in operations...

Learn More

Oliver Healthcare Packaging acquires Kansas City Design, forms new premium desig...

September 19, 2020

Trevose, Pennsylvania, USA – August 25, 2020 – Oliver Design LLC, a new business unit of Oliver Healthcare Packaging Company, a leading provider of global healthcare packaging, today announced the acquisition of Kansas City Design (KCD). KCD is a premier...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.